JP2020508298A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020508298A5 JP2020508298A5 JP2019543979A JP2019543979A JP2020508298A5 JP 2020508298 A5 JP2020508298 A5 JP 2020508298A5 JP 2019543979 A JP2019543979 A JP 2019543979A JP 2019543979 A JP2019543979 A JP 2019543979A JP 2020508298 A5 JP2020508298 A5 JP 2020508298A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- signaling pathway
- adipose
- tissue
- activator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023010078A JP7784392B2 (ja) | 2017-02-17 | 2023-01-26 | 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster) |
| JP2025129210A JP2025176014A (ja) | 2017-02-17 | 2025-08-01 | 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster) |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762460267P | 2017-02-17 | 2017-02-17 | |
| US62/460,267 | 2017-02-17 | ||
| US201762574119P | 2017-10-18 | 2017-10-18 | |
| US62/574,119 | 2017-10-18 | ||
| PCT/US2018/018684 WO2018152488A1 (en) | 2017-02-17 | 2018-02-20 | Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023010078A Division JP7784392B2 (ja) | 2017-02-17 | 2023-01-26 | 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020508298A JP2020508298A (ja) | 2020-03-19 |
| JP2020508298A5 true JP2020508298A5 (cg-RX-API-DMAC7.html) | 2021-04-01 |
Family
ID=63170490
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019543979A Pending JP2020508298A (ja) | 2017-02-17 | 2018-02-20 | 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat−associated lymphoid cluster) |
| JP2023010078A Active JP7784392B2 (ja) | 2017-02-17 | 2023-01-26 | 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster) |
| JP2025129210A Withdrawn JP2025176014A (ja) | 2017-02-17 | 2025-08-01 | 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster) |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023010078A Active JP7784392B2 (ja) | 2017-02-17 | 2023-01-26 | 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster) |
| JP2025129210A Withdrawn JP2025176014A (ja) | 2017-02-17 | 2025-08-01 | 移植、組織再生、器官形成及び複数の組織に対する機能のための部位としての脂肪関連リンパ球集積(fat-associated lymphoid cluster) |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20190374583A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3582794B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2020508298A (cg-RX-API-DMAC7.html) |
| KR (2) | KR102762505B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN119097642A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018221254B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019016965A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3052295A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3070490T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL268389B2 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2019009367A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018152488A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4427813A3 (en) * | 2019-04-11 | 2024-12-18 | University of Pittsburgh- Of the Commonwealth System of Higher Education | Minimally invasive cell transplant procedure to induce the development of in vivo organogenesis |
| WO2023076279A1 (en) * | 2021-10-25 | 2023-05-04 | Satellite Biosciences, Inc. | Engineered tissue constructs for the treatment of crigler-najjar syndrome |
| CN116925997B (zh) * | 2023-07-27 | 2024-04-02 | 湖北医药学院 | 左氧氟沙星在制备促进细胞增殖中的药物的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6312691B1 (en) | 1996-01-26 | 2001-11-06 | Jeffrey L. Browning | Lymphotoxin-α/β complexes and anti-lympotoxin-β receptor antibodies as anti-tumor agents |
| ATE371018T1 (de) * | 2001-06-22 | 2007-09-15 | Stemcells Inc | Le-zellen (liver engrafting cells), assays und verwendungen davon |
| US9125891B2 (en) * | 2008-03-07 | 2015-09-08 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Lymph nodes as a site for regeneration |
| WO2014138486A1 (en) * | 2013-03-06 | 2014-09-12 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs |
| US11191785B2 (en) * | 2008-03-07 | 2021-12-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs |
| AU2012352454A1 (en) * | 2011-12-15 | 2014-07-17 | The University Of Chicago | Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors |
-
2018
- 2018-02-20 IL IL268389A patent/IL268389B2/en unknown
- 2018-02-20 CN CN202411079982.8A patent/CN119097642A/zh active Pending
- 2018-02-20 MX MX2019009367A patent/MX2019009367A/es unknown
- 2018-02-20 JP JP2019543979A patent/JP2020508298A/ja active Pending
- 2018-02-20 CA CA3052295A patent/CA3052295A1/en active Pending
- 2018-02-20 KR KR1020197027026A patent/KR102762505B1/ko active Active
- 2018-02-20 WO PCT/US2018/018684 patent/WO2018152488A1/en not_active Ceased
- 2018-02-20 ES ES18754087T patent/ES3070490T3/es active Active
- 2018-02-20 AU AU2018221254A patent/AU2018221254B2/en active Active
- 2018-02-20 KR KR1020257002956A patent/KR20250020727A/ko active Pending
- 2018-02-20 CN CN201880025487.5A patent/CN110869032B/zh active Active
- 2018-02-20 EP EP18754087.7A patent/EP3582794B1/en active Active
- 2018-02-20 BR BR112019016965-2A patent/BR112019016965A2/pt active Search and Examination
-
2019
- 2019-08-06 MX MX2024005097A patent/MX2024005097A/es unknown
- 2019-08-16 US US16/542,490 patent/US20190374583A1/en not_active Abandoned
-
2023
- 2023-01-26 JP JP2023010078A patent/JP7784392B2/ja active Active
- 2023-08-23 US US18/454,646 patent/US20240091271A1/en active Pending
-
2024
- 2024-01-17 IL IL310219A patent/IL310219B2/en unknown
-
2025
- 2025-08-01 JP JP2025129210A patent/JP2025176014A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yu et al. | Macrophages play a key role in tissue repair and regeneration | |
| Lee et al. | Cartilage repair by mesenchymal stem cells: clinical trial update and perspectives | |
| Haider et al. | Bone marrow stem cell transplantation for cardiac repair | |
| Takahashi et al. | Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury | |
| Parolini et al. | Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table | |
| Zuba‐Surma et al. | Transplantation of expanded bone marrow‐derived very small embryonic‐like stem cells (VSEL‐SCs) improves left ventricular function and remodelling after myocardial infarction | |
| Hendijani et al. | Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin | |
| Kamei et al. | The use of endothelial progenitor cells for the regeneration of musculoskeletal and neural tissues | |
| CA2787992A1 (en) | Treatment of bone-related cancers using placental stem cells | |
| Guo et al. | Insulin-like growth factor 1 treatment of MSCs attenuates inflammation and cardiac dysfunction following MI | |
| Wang et al. | Intra-myocardial injection of both growth factors and heart derived Sca-1+/CD31− cells attenuates post-MI LV remodeling more than does cell transplantation alone: neither intervention enhances functionally significant cardiomyocyte regeneration | |
| Sullivan et al. | CSF-1R signaling in health and disease: a focus on the mammary gland | |
| Potter et al. | A strategy to eradicate well-developed Krebs-2 ascites in mice | |
| Haneef et al. | Role of interleukin‐7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo | |
| Enzmann et al. | CXCL12/SDF-1-dependent retinal migration of endogenous bone marrow-derived stem cells improves visual function after pharmacologically induced retinal degeneration | |
| Kopeina et al. | Programmed cell death and tissue regeneration: a link that should be resolved | |
| KR20160006669A (ko) | 5-브로모-인디루빈 | |
| Dariolli et al. | Allogeneic pASC transplantation in humanized pigs attenuates cardiac remodeling post-myocardial infarction | |
| Ling et al. | Pretreatment of rat bone marrow mesenchymal stem cells with a combination of hypergravity and 5‐azacytidine enhances therapeutic efficacy for myocardial infarction | |
| KR102082185B1 (ko) | 저분자 화합물을 이용한 골격근육세포 분화 방법 | |
| Rannou et al. | Human MuStem cell grafting into infarcted rat heart attenuates adverse tissue remodeling and preserves cardiac function | |
| Luo et al. | Low-intensity pulsed ultrasound alleviating myelosuppression of Sprague-Dawley rats after combined treating by paclitaxel and carboplatin | |
| KR101694554B1 (ko) | 자연살해세포 억제제 및 간엽줄기세포를 유효성분으로 포함하는 이식편대숙주질환의 예방 또는 치료를 위한 세포치료제 조성물 | |
| Sencan et al. | Cellular parabioisis as a senotherapeutic approach | |
| Ferry et al. | Liver regeneration: with a little help from marrow |